Status:
RECRUITING
Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Obesity Patients
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Hypoxia
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Gastroscopy is a commonly used, direct, and reliable method for screening and diagnosing digestive tract diseases. However, as an invasive examination, it can cause adverse reactions such as pain, nau...
Detailed Description
Gastroscopy is a commonly used, direct, and reliable method for screening and diagnosing digestive tract diseases. However, as an invasive examination, it can cause adverse reactions such as pain, nau...
Eligibility Criteria
Inclusion
- Patients undergoing painless gastroscopy;
- Patients with an age greater than 18 years old;
- American Society of Anesthesiologists (ASA) physical status classification from Grade I to Grade III;
- Body Mass Index (BMI) greater than 28 kg/m²
Exclusion
- Patients with contraindications to endoscopic procedures or those who refuse sedation/anesthesia;
- Patients allergic to propofol, eggs, soybeans, milk, etc.;
- Patients with gastrointestinal tract obstruction and gastric emptying disorders;
- Patients with acute pharyngitis, tonsillitis, and upper respiratory tract infections;
- Patients in the acute exacerbation stage of respiratory diseases such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD);
- Patients with acute arrhythmia and those with severe heart diseases (congenital diseases, valvular diseases);
- Patients with severe hepatic and renal insufficiency who require alternative treatment;
- Patients with severe mental disorders who need medications to control their symptoms;
- Patients with moderate or above anemia, abnormal coagulation function, and hematological diseases;
- Patients with nasal cavity lesions leading to severe nasal congestion;
- Pregnant and lactating patients.
Key Trial Info
Start Date :
May 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
364 Patients enrolled
Trial Details
Trial ID
NCT06966934
Start Date
May 14 2025
End Date
May 31 2026
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing First Hospital
Nanjing, China